Lastly, in other critically ill patient populations, recently successful evaluation of pharmacological interventions in a translational matter have been performed (i.e., protein kinase inhibitors in acute respiratory distress syndrome). The gene discussed is WEE1; the disease is acute respiratory distress syndrome.